Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

66 results about "Tedizolid" patented technology

This medication is used to treat serious bacterial infections of the skin.

Method for testing content of tedizolid phosphate enantiomer through high performance liquid chromatography

The invention discloses a method for testing the content of tedizolid phosphate enantiomer through high performance liquid chromatography. The method comprises the following steps: (1) preparing a test solution, namely precisely weighing tedizolid phosphate, diluting with a mobile phase, and uniformly shaking so as to obtain the test solution; (2) preparing a control solution, namely precisely weighing the test solution, diluting with the mobile phase, and uniformly shaking so as to obtain the control solution; (3) testing the content, namely respectively injecting the control solution and thetest solution into a liquid chromatography meter, recording spectrums, and calculating the content of the tedizolid phosphate enantiomer by using a self-contrasted method, wherein the mobile phase ismethanol-acetonitrile-acetic acid-ammonium acetate. By selecting spectrum conditions, tedizolid phosphate and enantiomer impurities of the tedizolid phosphate can be simply, rapidly and accurately separated and detected, and controllable quality of tedizolid phosphate and a preparation of the tedizolid phosphate is achieved. Development of synthesis processes is instructed, and quality standard formulation of tedizolid phosphate raw material medicines can be facilitated.
Owner:成都美域高制药有限公司

Preparation method of tedizolid phosphate freeze-dried preparation for injection

The invention relates to the technical field of pharmaceutical preparations, and particularly discloses a preparation method of a tedizolid phosphate freeze-dried preparation for injection. The preparation method of the tedizolid phosphate freeze-dried preparation for injection comprises the following steps: a, adding tedizolid phosphate and a freeze-drying protective additive into water for injection to obtain tedizolid phosphate liquid medicine; b, sequentially cooling the liquid medicine to -8 to -10 DEG C and -40 to -50 DEG C, and keeping for a specific time; heating the liquid medicine to -15 DEG C to -10 DEG C, and cooling the liquid medicine to -40 DEG C to -50 DEG C, and keeping the temperature for a certain period to obtain a freeze-dried product; c, under the vacuum condition, heating the freeze-dried product to -30 to -10 DEG C and 40 to 50 DEG C, and keeping the temperature for a certain period, so as to obtain the tedizolid phosphate freeze-dried preparation for injection. The preparation method is simple to operate, the time cost for preparing the tedizolid phosphate freeze-dried preparation for injection is remarkably reduced, and the high-quality tedizolid phosphate freeze-dried preparation for injection, which is low in impurity and moisture content, can be obtained.
Owner:SHIJIAZHUANG NO 4 PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products